US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five ...

The biotech has secured $65m in a Series A funding round led by Cormorant Asset Management and other investors.

Creating a novel drug has always been a risky endeavor for biopharmaceutical companies. Developers and investors face ...

USA News Group ? Cancer rates are rising globally, and the outlook is particularly concerning for men. A recent global study projects an 84% increase in cancer cases and a 93% rise in cancer deaths ...

Some patients with psoriasis who were treated with guselkumab and achieved complete skin clearance experienced a persistent impact on quality of life.

The global skincare market is set for substantial growth, with an estimated valuation of USD 166,870.4 million in 2024.

Vivek Ramaswamy, the biotech entrepreneur who competed for the Republican presidential nomination, hosted a town hall meeting ...

UNION therapeutics A/S (UNION), a privately held, clinical stage, pharmaceutical development company focused on immunology, today announced ADESOS Phase 2b results selected as a late-breaking oral ...

Risky but with rewards, Australian pharmaceutical companies developing treatments for rare diseases are competing for ...

A research team has successfully recreated the structure of wrinkles in biological tissue in vitro, uncovering the mechanisms behind their formation.

Hunan Engineering Technology Research Center of Featured Aquatic Resources Utilization, Fisheries College, Hunan Agricultural University Changsha, Hunan, 410128, China State Key Laboratory of ...

The end of the trading week likely can't come fast enough for Vanda Pharmaceuticals (NASDAQ: VNDA). The commercial-stage ...